This broad and unbeatable Global Distribution Network enables DIH to provide effective coverage & service to customers around the world. The hub-and-spoke business model means that the visions born at the headquaters of chief brands of DIH, located in Zurich and Houten, are represented both globally and at a local level.

2025年1月28日 · We offer an integrated solution for the entire continuum of care and multiple markets including Hospitals, Clinics, Research and Home. For over 20 years our brands have been working with some of the most pioneering facilities in rehabilitation to develop new and better ways to treat patients. Learn about those institutions and patients here.

DIH’s i-Pharm solutions, including out-patient, central, and in-patient pharmacy solutions, help improve hospital medication management systems. DIH was founded in 2009 and is headquartered in Beijing, China.

The team leading DIH are counted amongst some of the most pioneering, respected and seasoned management in the industry, each coming from more than 20 years of experience.

ABILITATION EQUIPMENT HANOVER, MD and BEIJING, CHINA - BTE is pleased to announce the naming of DIH Technology (China) as its representative in The People’s Republic of China, bringing innovative therapeutic technology to p.

蝶和科技（中国）有限公司是⼀家成⽴于2015年02月10日的有限责任公司，也是DIH INTERNATIONAL LIMITED旗下企业，属于以从事科学研究和技术服务业为主的企业。 位于北京市海淀区，法定代表人为陈济海，目前处于存续状态。

DIH Technologies is headquartered in Beijing, China. What is the size of DIH Technologies? DIH Technologies has 192 total employees. What industry is DIH Technologies in? DIH Technologies’s primary industry is Other Healthcare Technology Systems. Is DIH Technologies a private or public company? DIH Technologies is a Public company.

DHI 中国

DIH has combined the best innovations and people needed to be the market leader in advanced rehabilitation technology. As the parent company behind brands Hocoma, Motek and others, DIH can be...

Explore DIH (China) Technology Co. Ltd. with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, 14 news.